Next Generation Sequencing Market Research Reports & Industry Analysis
The next generation sequencing (NGS) industry is altering our understanding of genetics and leading to advancements in healthcare, agriculture, and other critical areas. NGS market growth is being driven by decreasing cost, rapid turnaround times, and the rise of high throughput sequencing, with the power to facilitate large-scale population studies, microbiome research, and cancer genomics. MarketResearch.com provides a collection of next generation sequencing industry reports to help you navigate this evolving landscape and gain in-depth insights.
Next Generation Sequencing Market Analysis
- Drawing on extensive primary and secondary research, our reports provide expert market analysis, company profiles, and strategic recommendations.
- We explain how the next generation sequencing market is evolving, and how you can ensure you are at the forefront of the market.
- In addition, our research pinpoints the most lucrative areas of the market, so you can capitalize on them at the right time.
A Research Partner You Can Trust
With more than two decades of experience in the field, MarketResearch.com has long served a range of clients including leading investment banks, management consulting firms, and Fortune 500 multinational corporations. We collect reports from hundreds of leading firms to create a convenient source of insights accessible through a single platform. Each step of the way, our dedicated research specialists are available to offer expert guidance and recommendations.
Next Generation Sequencing Industry Research & Market Reports
-
NGS Library Preparation Market by Products (Instruments, Kits, Reagents & Consumables), Application (Diagnostics, Drug & Biomarker Research, Precision Medicine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 2.83 billion in 2024, at a CAGR 14.85% to reach USD 6.53 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Non-Invasive Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Technology (Next Generation Sequencing (NGS), RT-PCR and dPCR), End-user - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.19 billion in 2024, at a CAGR 18.10% to reach USD 3.25 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Non-Invasive ... Read More
-
Next-Generation Gynecological Cancer Diagnostics Market by Components (Consumables, Instruments, Software), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), Indication, End User - Global Forecast 2024-2030
... USD 2.13 billion in 2023 and expected to reach USD 2.32 billion in 2024, at a CAGR 10.49% to reach USD 4.29 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Lung Cancer Genomic Testing Market by Technology (Fluorescence In Situ Hybridization, Next-Generation Sequencing, Polymerase Chain Reaction), Sample Type (Liquid Biopsy, Tissue Biopsy), Panel Type, End User - Global Forecast 2024-2030
... Market size was estimated at USD 1.01 billion in 2023 and expected to reach USD 1.07 billion in 2024, at a CAGR 8.00% to reach USD 1.73 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Global Protein Sequencing Market Research Report 2024(Status and Outlook)
... exhibiting a CAGR of 5.40% during the forecast period. This report provides a deep insight into the global Protein Sequencing market covering all its essential aspects. This ranges from a macro overview of the market ... Read More
-
Global Next Generation Sequencing (NGS) Preparation Market Research Report 2024(Status and Outlook)
... from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Global Transcriptomics Market Research Report 2024(Status and Outlook)
... of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies ... Read More
-
Global Next-generation Sequencing Services Market Size Study & Forecast, by Type (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Other Sequencing Services), by Workflow (Pre-sequencing, Sequencing, Data Analysis), by End-use (Universities & Other Research Entities, Hospitals & Clinics, Others), and Regional Analysis, 2023-2030
... Entities, Hospitals & Clinics, Others), and Regional Analysis, 2023-2030 Global Next-generation Sequencing Services Market is valued at approximately USD 4.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Spatial Genomics Market by Type (Genomics, Transcriptomics) Technology (Sequencing, Imaging) Application (Oncology, Neurology) Offering (Consumables, Instrument, Software) End User (Pharmaceutical & Biotechnology, CRO) - Global Forecast to 2031
... Technology (Sequencing, Imaging) Application (Oncology, Neurology) Offering (Consumables, Instrument, Software) End User (Pharmaceutical & Biotechnology, CRO)—Global Forecast to 2031 The global spatial genomics & transcriptomics market is expected to reach $3.23 billion by 2031 at ... Read More
-
North America Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
... Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, ... Read More
-
South & Central America Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
... Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & ... Read More
-
Europe Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
... DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and ... Read More
-
Middle East & Africa Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
... Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & ... Read More
-
Moderna Inc (MRNA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Findings. This unique new report provides deep financial benchmarks for Moderna Inc (MRNA:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Moderna ... Read More
-
Bioinformatics Market based on by Technology & Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services), Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, and Others), and Sector (Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others), Regional Outlook– Global Forecast up to 2030
... and Others), Regional Outlook– Global Forecast up to 2030 Many governments and business organisations throughout the world are investing in bioinformatics. These expenditures have resulted in technical breakthroughs in bioinformatics services, which have increased their ... Read More
-
Asia Pacific Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
... Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, ... Read More
-
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024
... bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug discovery for rare diseases, obesity, and oncology. The possibility of targeting previously undruggable targets will drive ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassay, Next-generation Sequencing (NGS), Insitu Hybridization, Mass, Spectrometry, PCR, Microarray, and Others) by Biomarker Type (Genomic Biomarkers, and Protein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), and by Application (Research Application and Clinical Application) – Global Opportunity Analysis and Industry Forecast, 2024–2030
... and by Application (Research Application and Clinical Application) – Global Opportunity Analysis and Industry Forecast, 2024–2030 Cancer/Tumor Profiling Market was valued at USD 11.75 billion in 2023, and is slated to surpass USD 26.57 billion ... Read More
-
Europe Diagnostics Tests Market - Industry Trends and Forecast to 2033
... to reach USD 133,167,940.95 thousand by 2031 from USD 72,092,456.93 thousand in 2023. Market Segmentation Europe Diagnostic Tests Market, By Type (Routine Tests and Specialized Tests), Component (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gen ... Read More
-
Global Diagnostics Tests Market - Industry Trends and Forecast to 2031
... expected to reach USD 264,171,700.00 thousand by 2031 from USD 495,851,713.97 thousand in 2023. Market Segmentation Global Diagnostic Tests Market, By Type (Routine Tests and Specialized Tests), Component (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next ... Read More
-
Non Invasive Prenatal Testing (NIPT) Market Forecasts to 2030 – Global Analysis By Product (Disposables, Ultrasound Devices, Assay Kits & Reagents, Polymerase Chain Reaction Instruments, Next-Generation Sequencing Systems, Microarrays and Other Products), Method, Gestation Period, Technology, Application, End User and By Geography
... Technology, Application, End User and By Geography According to Stratistics MRC, the Global Non-Invasive Prenatal Testing (NIPT) Market is accounted for $4.2 billion in 2023 and is expected to reach $9.1 billion by 2030 growing ... Read More
-
mRNA Vaccines in Infectious Diseases Market Overview
... Current Companies and Brief Market Outlook Messenger RNA (mRNA) is a single-stranded ribonucleic acid that is transcribed from a strand of DNA. mRNA carries the coding information for protein synthesis. mRNA vaccines use mRNA that ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research ... Read More
-
Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Next Generation Sequencing (NGS) Tests pipeline products with comparative analysis of the products at various ... Read More